Agios Pharmaceuticals

Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism

placeCambridge, Massachusetts, United States calendar_todayFounded 2008 groups383 employees language agios.com

Registered entities

Social engagement

Social engagement: 103.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Celgene, Arch Venture Partners, Third Rock Ventures, Flagship Pioneering.

Investor typeCountShare
Venture capital450%
Private equity225%
Other / undisclosed225%
Coming soon